Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
EGFR/PI3K/AKT 通路的激活限制了曲美替尼治疗头颈癌的疗效
期刊:Molecular Oncology
影响因子:5
doi:10.1002/1878-0261.13500
Ofra Novoplansky, Avital B Shnerb, Divyasree Marripati, Sankar Jagadeeshan, Raghda Abu Shareb, Cristina Conde-López, Jonathan Zorea, Manu Prasad, Talal Ben Lulu, Ksenia M Yegodayev, Chen Benafsha, Yushi Li, Dexin Kong, Fengshen Kuo, Luc G T Morris, Ina Kurth, Jochen Hess, Moshe Elkabets